Genomic Valley Biotech Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 0.2898 million compared to INR 0.66969 million a year ago. Revenue was INR 0.2898 million compared to INR 0.66969 million a year ago. Net loss was INR 0.571655 million compared to INR 0.263696 million a year ago. Basic loss per share from continuing operations was INR 0.19 compared to INR 0.09 a year ago. Diluted loss per share from continuing operations was INR 0.19 compared to INR 0.09 a year ago. For the six months, sales was INR 0.4594 million compared to INR 0.94729 million a year ago. Revenue was INR 0.4594 million compared to INR 0.94729 million a year ago. Net loss was INR 1.66 million compared to INR 1.62 million a year ago. Basic loss per share from continuing operations was INR 0.54 compared to INR 0.53 a year ago. Diluted loss per share from continuing operations was INR 0.54 compared to INR 0.53 a year ago.